| P2093 | author name string | Warren S Joseph | |
| P2860 | cites work | Diabetic foot ulcers: current concepts | Q77496876 |
| | Manifestation of cellulitis after saphenous venectomy for coronary bypass surgery | Q78507128 |
| | Skin and wound infections: an overview | Q28272752 |
| | Epidemiology of methicillin-resistant Staphylococcus aureus | Q33537224 |
| | Infections in patients with diabetes mellitus | Q33796634 |
| | Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate | Q34284305 |
| | Diagnosis and treatment of diabetic foot infections | Q34357233 |
| | A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients | Q34408275 |
| | Management of lower leg cellulitis | Q34547994 |
| | Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides | Q35111936 |
| | Common pathogens and differential diagnosis of skin and soft tissue infections. | Q35795071 |
| | Preventing cellulitis in older people with persistent lower limb oedema | Q35851072 |
| | Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review | Q36043660 |
| | Treatment options in the management of uncomplicated skin and skin structure infections | Q36055110 |
| | Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use. | Q37917074 |
| | Microbiology and antimicrobial therapy of diabetic foot infections | Q37952719 |
| | The diabetic foot. Soft tissue and bone infection. | Q37962534 |
| | Cellulitis: analysis of 101 cases and review of the literature. | Q40279480 |
| | Diabetic foot infections. Antimicrobial therapy. | Q40538281 |
| | Assessment and management of foot disease in patients with diabetes | Q40587446 |
| | Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevance | Q41676876 |
| | Osteomyelitis of the foot in diabetic patients | Q41683213 |
| | Predicting nonelective hospitalization: a model based on risk factors associated with diabetes mellitus | Q42082802 |
| | The management of skin and skin structure infections in children, adolescents and adults: a review of empiric antimicrobial therapy. | Q43478726 |
| | Erysipelas and group G streptococci | Q43529227 |
| | Non-group A beta-hemolytic streptococcal cellulitis. Association with venous and lymphatic compromise | Q43728471 |
| | Highly resistant pathogens in patients with diabetic foot syndrome with special reference to methicillin-resistant Staphylococcus aureus infections | Q43811501 |
| | Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem | Q44311731 |
| | Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates | Q45020146 |
| | Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. | Q45981790 |
| | Methicillin-resistant Staphylococcus aureus disease in three communities | Q46426018 |
| | The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. | Q50629791 |
| | Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group. | Q53830093 |
| | Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples. | Q53980348 |
| | Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. | Q54076915 |
| | Oral clindamycin and ciprofloxacin therapy for diabetic foot infections | Q56766314 |
| | Outpatient management of uncomplicated lower-extremity infections in diabetic patients | Q68504368 |
| | Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both | Q69505595 |
| | Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique | Q69505886 |
| | Streptococcal cellulitis proved by skin biopsy in a coronary artery bypass graft patient | Q69870536 |
| | Bacteria in superficial diabetic foot ulcers | Q73329852 |
| | [Erysipelas. A retrospective series of 92 patients in a department of internal medicine] | Q73668360 |
| | Infection of foot ulcers with Staphylococcus aureus associated with increased mortality in diabetic patients | Q73697045 |
| | Clinical practice guideline: management of sinusitis | Q74454509 |
| | Recent Considerations in Recurrent Cellulitis | Q74519524 |
| P433 | issue | 5 | |
| P304 | page(s) | 384-389 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | Current infectious disease reports | Q26842136 |
| P1476 | title | Optimal management of uncomplicated skin and skin structure infections of the lower extremity | |
| P478 | volume | 8 | |